PSMA Therapy Delays Hormone Treatment in Prostate Cancer Patients
Radboud University Medical Center’s recent Phase 2 trial, published in The Lancet Oncology, demonstrates that Prostate-Specific Membrane Antigen (PSMA) therapy can significantly delay the need for hormone therapy in men ... Read More